Thank you for subscribing!
Next Investors Archived Nov 07, 2016
The medicinal cannabis industry, whilst attracting a lot of publicity, is still in its early stages as a new niche with very few current or even experienced market participants. Even the big pharma companies have so far been apprehensive towards taking significant stakes in medicinal cannabis, and have preferred to wait out the legislative rigmarole making headlines in the US, Europe and Australia.
Finfeed Archived Mar 30, 2016
Australia’s first ever White Paper on medical cannabis, authored by the University of Sydney in collaboration with MGC Pharmaceuticals, shows a blooming A$150 million industry in need of 8,000kg.
Next Investors Archived Jan 21, 2016
Last week a crucial piece of news hit emerging pharmaceutical company MMJ Phytotech (ASX:MMJ). In what is known as a ‘Pre-License Inspection’, Federal health inspectors at Health Canada will examine MMJ’s Canadian medicinal cannabis growing facilities.
Get expert stock analysis direct in your inbox
Join Our Mailing List
